MacroGenics | MGNX - Interest Expense On Debt


MacroGenics reported $4.4M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
AbbVie USD 688M 58M Sep/2026
Amgen USD 653M 94.99B Sep/2026
AstraZeneca USD 371M 31M Sep/2026
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 403M 4M Sep/2026
Daiichi Sankyo JPY 14.13B 10.56B Sep/2026
Eli Lilly USD 316M 201.3M Sep/2026
Genmab DKK 139M 129M Jun/2026
Geron USD 7.21M 61K Sep/2026
Gilead Sciences USD 269M 22M Sep/2026
J&J USD 43M 25M Mar/2026
Karyopharm Therapeutics USD 12.55M 66K Mar/2026
MacroGenics USD 4.4M 493K Jun/2026
Merck USD 525M 46M Jun/2026
Pfizer USD 662M 5M Sep/2026
Puma Biotechnology USD 3.37M 11K Jun/2024
Regeneron Pharmaceuticals USD 11M 1.9M Jun/2026
Roche Holding CHF 304M 7.5M Jun/2025
Xencor USD 4.11M 3.24M Sep/2026